Joshua Levine

Joshua Levine is a declared insider at 4 companies (chief executive); the most frequent names are Accuray Inc, Mentor Corp /MN/ and Natus Medical Inc. We count 127 filings; the first trade dates from 15 August 2006 and the latest from 14 August 2026.

Market trades split into 10 purchases (€1.7M) and 62 sales (€5.2M). The net balance comes to €3.4M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 43 share grants and 7 option exercises. Since January 2026: 1 purchase and no sales on the market.

Half of the purchases are above €73k and half below.

The record was last updated on 17 August 2026 with an open-market purchase (€41k) in Edap TMS SA. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.